Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis

[1]  C. Vedeler,et al.  [Neuromuscular complications of sepsis]. , 2001, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[2]  K. Werdan,et al.  Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis. , 1997, Chest.

[3]  C. Bolton,et al.  Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. , 1996, Critical care medicine.

[4]  D. Krieger,et al.  Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. , 1996 .

[5]  F. Leijten,et al.  The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. , 1996, JAMA.

[6]  K. Werdan,et al.  Supplemental immune globulins in sepsis: a critical appraisal , 1996, Clinical and experimental immunology.

[7]  S. Kaveri,et al.  Mechanisms of action of intravenous immune globulin in immune‐mediated diseases , 1996, Clinical and experimental immunology.

[8]  E. Wijdicks,et al.  Failure of high dose intravenous immunoglobulins to alter the clinical course of critical illness polyneuropathy. , 1994, Muscle & nerve.

[9]  F. Leijten,et al.  Critical illness polyneuropathy a review of the literature, definition and pathophysiology , 1994, Clinical Neurology and Neurosurgery.

[10]  I. L. Cohen.  Guidelines for the use of innovative therapies in sepsis. , 1993, Critical care medicine.

[11]  C. Bolton,et al.  The neurological complications of sepsis , 1993, Annals of neurology.

[12]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[13]  T. Clemmer,et al.  Prolonged paralysis after treatment with neuromuscular junction blocking agents , 1991, Critical care medicine.

[14]  A. Ballabio,et al.  Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. , 1991, Archives of surgery.

[15]  S. Iannaccone,et al.  Prolonged myasthenic syndrome after one week of muscle relaxants. , 1990, Pediatric neurology.

[16]  R. Miller,et al.  Prolonged neuromuscular blockade after long-term administration of vecuronium in two critically ill patients. , 1990, Anesthesiology.

[17]  C. Bolton,et al.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.

[18]  W. Sibbald,et al.  Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[19]  H. Laak,et al.  Neuromuscular complications in patients given pavulon/sr (pancuronium bromide) during artificial ventilation , 1985, Clinical Neurology and Neurosurgery.

[20]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[21]  R. Goris,et al.  Multiple-organ failure. Generalized autodestructive inflammation? , 1985, Archives of surgery.

[22]  H. Ellman.  Capillary permeability in septic patients. , 1984, Critical care medicine.

[23]  R. Beart,et al.  Multiple organ failure. , 1977, Surgery, gynecology & obstetrics.

[24]  S. Baker,et al.  The injury severity score: an update. , 1976, The Journal of trauma.

[25]  M. Ramsay,et al.  Controlled Sedation with Alphaxalone-Alphadolone , 1974, British medical journal.

[26]  A. Groeneveld,et al.  The haemodynamics of septic shock , 2005, Intensive Care Medicine.

[27]  J. L. López Messa,et al.  Acute polyneuropathy in critically ill patients , 2005, Intensive Care Medicine.

[28]  M. Kofler,et al.  Ethical problems in intensive care medicine and case reporting , 2005, Intensive Care Medicine.

[29]  A. Baue,et al.  Multiple Organ Failure , 2000, Springer New York.

[30]  K. Werdan,et al.  Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. , 1994, Chest.

[31]  H. Kress.  What Is Certain in the Treatment with Immunoglobulins , 1994 .

[32]  R. Dellinger,et al.  Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. , 1993, Critical care medicine.

[33]  W. Sibbald,et al.  Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.

[34]  I. Schedel,et al.  [Properties and efficacy of a human immunoglobulin M preparation for intravenous administration]. , 1985, Arzneimittel-Forschung.